Orthostatic hypotension induced by sertraline withdrawal

Pharmacotherapy

Volumn 16, Issue 4, 1996, Pages 684-686

  Amsden, Guy W ^a,c   Georgian, Frederick ^b  

^a Clin Pharmacology Research Center   (United States)

^b Fallon Medical Center   (United States)

^c BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE; SERTRALINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; DEPRESSION; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; ORTHOSTATIC HYPOTENSION; VERTIGO; WITHDRAWAL SYNDROME;

1-NAPHTHYLAMINE; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029835815     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Guthrie SK. Sertraline: a new specific serotonin reuptake blocker. Ann Pharmacother 1991;25:952-61.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington, DC: Author, 1980:205-24, 225-39.
3. Koe BK, Weissman A, Welch WM, Browne RG. Sertraline, 1S, 4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 1983;226:686-700.
4. Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994;24:490-4.
5. Mattila MJ, Saarialho-Kere U, Mattila M. Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance of healthy subjects over 50 years of age. J Clin Psychiatry 1990;51(12 suppl B):37-9.